摘要
目的:评价氟罗沙星与阿奇霉素治疗非淋菌性尿道(宫颈)炎的成本-效果。方法:76例非淋菌性尿道(宫颈)炎门诊患者随机分为A、B组,分别给予氟罗沙星与阿奇霉素治疗7d,运用成本-效果分析法进行评价。结果:A、B组的成本分别为870．50元、557．46元,有效率分别为92．3％、94．6％(P>0．05),成本-效果比分别为943．12、589．28。结论:阿奇霉素相对于氟罗沙星治疗非淋菌性尿道(宫颈)炎具有明显的药物经济学优势。
OBJECTIVE ：To evaluate the cost- effectiveness of fleroxacin and azithromycin for non- gonococcal urethritis or cervicitis.METHODS： A total of 76 cases with non- gonococcal urethritis or cervicitis were assigned to receive fleroxacin （Group A） or Azithromyein（Group B） for 7 days,and the cost- effectiveness of the 2 groups was evaluated .RESULTS：The costs of the fleroxacin group and azithromyein group were 870.50 yuan and 557.46 yuan, respectively; the effective rates were 92.3 % and 94.6%, respectively（P 〉 0.05） .The cost - effevtiveness ratios were 943.12 and 589.28, respectively. CONCLUSION： The therapy of azithromycin has marked pharmaeoeconomies advantage over fleroxacin in treating non- gonococcal urethritis or cervicitis.
出处
《中国药房》
CAS
CSCD
北大核心
2007年第2期91-92,共2页
China Pharmacy
